Stay updated on Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T14:25:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-05-01T06:26:02.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the addition of new drugs for treating graft-versus-host disease (GVHD) and the removal of detailed study information regarding ruxolitinib's efficacy. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    9%
    Check dated 2025-04-16T20:39:53.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.2%
    Check dated 2025-04-09T14:41:56.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.2%
    Check dated 2025-04-02T00:20:00.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-11T07:57:14.000Z thumbnail image

Stay in the know with updates to Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.